Summary

BNC Korea
CEO Wangyu Choi
Date of Incorporation 08.01.2007
Location 62 Daegu Techno Venture Plant district 1, 405-ho, Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu, Korea
Main Business Production and Development of Medical Biocompatible Materials
Main Product - Biomaterials for Tissue Repair (Hyaluronic acid Filler)
- Covering Materials for Deep Wound in the Coelom (Hibarry )
- Absorbent Collagen Covering Materials for Wound (GENTA Q )
Technology Competitiveness - First Development of Filler among Bio Venture Companies in Korea
- Manufacturing equipment and methods for Particles in the hyaluronic acid derivatives (patent no. 10-1223652)
- Best Compounding Technology to prevent synechia
- Specialized products for various purposes
- Completion of developing Absorbent Collagen Covering Materials for Wound domestically
Technical Certificate -Registration of a patent for manufacturing equipment and methods of particles in the hyaluronic acid derivatives
- Acquisition of filler for wrinkle care and an antisynechia, certified by CE
- ISO 13485(2012) Acquisition of filler for alleviating wrinkles and an antisynechia
- ISO 14001(2004) Acquisition of filler for alleviating wrinkles, an antisynechia and functional cosmetic
- ISO 9001(2008) Acquisition of filler for alleviating wrinkles, an antisynechia and functional cosmetic
- Confirmation for laboratory affiliated with the company
- Identification as a Technology Innovative Small Buisness (INNO-BIZ)

Business/ Marketing:42 Damyung Building 5th floor, Nonhyeon-ro 38-gil, Gangnam-gu, Seoul, Korea 
Head office/ Laboratory: 62 Daegu Techno Venture Plant district 1, 405-ho, Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu, Korea
Product inquiries (capital region) :02-3142-3900   Product inquiries (Noncapital region): 070-7116-0059  Corporate Registration Number: 124-86-58215 | CEO: Wangyu Choi
Copyright © 2017 BNC Korea. ALL RIGHT RESERVED.